Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2030

Annual patent cliff calendar for 2030 — US pharmaceutical patents by expiration date.

Patents
905

Quick answer

905 indexed pharmaceutical patents have expiration dates in 2030. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 7820663

    Substituted enaminones, their derivatives and uses thereof

    The Regents of the University of California · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7820671

    Peptidomimetic protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7820685

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7820692

    Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7820733

    Dental polymerizable core build-up material of separately packed type

    Kuraray Medical Inc. · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7820837

    Condensed ring compound

    Takeda Pharmaceutical Company Limited · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7820784

    Orally administered peptides synergize statin activity

    The Regents of the University of California · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7820817

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7820819

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7820162

    Methods for chemically synthesizing immunoglobulin chimeric proteins

    Syntonix Pharmaceuticals, Inc. · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7820174

    T cell receptors and related materials and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7820181

    Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7820182

    Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7820447

    Compositions and methods for cancer

    Sagres Discovery, Inc. · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7820642

    Nandrolone 17β-carbonates

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7820673

    Urea derivative, process for producing the same, and use

    Takeda Pharmaceutical Company Limited · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7820634

    Composition and method for production of transformed cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7820695

    Selective serotonin receptor inverse agonists as therapeutics for disease

    ACADIA Pharmaceuticals Inc. · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 2010273803

    Oral Formulations for Tetrapyrrole Derivatives

    CERAMOPTEC IND INC [DE] · Granted Thu Oct 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7825142

    Heterocyclic compounds, compositions comprising them and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7825127

    Method for treating cancer

    Takeda Pharmaceutical Company Limited · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7825136

    Potentiators of antibacterial activity

    Vertex Pharmaceuticals Incorporated · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7825116

    N2, N4-bis-aryl-5-fluoro-2,4-pyrimidinediamines

    Rigel Pharmaceuticals, Inc. · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7824680

    Methods for inhibiting angiogenesis

    The Regents of the University of California · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7824697

    High concentration baclofen preparations

    The Board of Regents of the University of Texas System · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7824682

    Cardiac myosin light chain kinase-specific antibodies and methods of detecting

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7825231

    Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7825159

    Mixtures of aromatic esters for marking or tagging organic products, marker compositions comprising the same and manufacturing methods thereof

    UNITED COLOR MANUFACTURING, INC. · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7825150

    Compositions and methods for treating immunological and inflammatory diseases and disorders

    LEXICON PHARMACEUTICALS, INC. · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7825126

    Purine derivatives as A3 and A1 adenosine receptor agonists

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7824690

    Marek's disease virus vaccine

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7824681

    Human monoclonal antibodies that specifically bind IGF-II

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7825102

    Treatment of dry eye conditions

    CAN-FITE BIOPHARMA LTD. · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7825154

    Small molecule inhibitors of botulinum neurotoxins

    The United States of America as represented by the Secretary of the Army · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7825242

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7824695

    Delivery of proteins across polar epithelial cell layers

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7825092

    Dendroaspis natriuretic peptide for treatment of cancer

    United States Department of Veteran Affairs · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7825278

    Substituted enaminones, their derivatives and uses thereof

    The Regents of the University of California · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7825096

    O6-alkylguanine-DNA alkyltransferase inactivators and beta-glucuronidase cleavable prodrugs

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7825265

    Compounds with activity at estrogen receptors

    ACADIA Pharmaceuticals Inc. · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7825269

    Ligands for nematode nuclear receptors and uses thereof

    The Board of Regents of the University of Texas System · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7825216

    Phenylanine derivatives

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 2010280048

    Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase

    ASTRAZENECA R & D [SE] · Granted Thu Nov 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 2010280081

    ANTI-INFLAMMATORY AGENTS AS VIROSTATIC COMPOUNDS

    4SC AG [DE] · Granted Thu Nov 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7829561

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7829081

    Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

    HALOZYME, INC. · Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7829728

    Diarymethyl and related compounds

    Theravance, Inc. · Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7829693

    Compositions and methods for inhibiting expression of a target gene

    Alnylam Pharmaceuticals, Inc. · Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2030?

905 published patents in our USPTO index have expiration dates falling in calendar year 2030.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.